Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION (MCK)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

McKesson Corporation : McKesson and Epic Settle Patent Infringement Litigation

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/04/2013 | 08:11pm CEST


Settlement allows companies to focus on needs of customers

SAN FRANCISCO, March 4, 2013 - McKesson Corporation and Epic Systems Corporation have settled their longstanding patent infringement litigation involving McKesson's U.S. patent #6,757,898 and Epic's MyChart software. 

Under terms of the settlement, McKesson agreed to grant Epic a license to the patent for the benefit of Epic and its customers.  In exchange, Epic agreed that it will no longer contest the validity of the patent, allowing McKesson and Epic to return to normalcy in their relationship going forward.  The parties also agreed to dismiss all pending claims and counterclaims and end any further litigation and appeals.

Executives from both parties recognized the settlement as one that will benefit the healthcare industry in general, and allow both parties to focus on the needs of their customers. 

"We're delighted to have settled this litigation with McKesson," said Carl Dvorak, chief operating officer, Epic Systems Corporation.

"We look forward to reestablishing our prior relationship and exploring new opportunities to serve our mutual customers," echoed Jeff Felton, president of McKesson's RelayHealth business. "Both companies will benefit by putting this litigation behind us."

About McKesson Corporation

McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.www.mckesson.com.

PR Contact

Kris Fortner
415.983.8352
[email protected]



distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MCKESSON CORPORATION
05:10pMCKESSON : How to Get Your Specialty Practice Ready for CAR-T Cell Therapies
PU
03:15pMCKESSON CORPORATION : annual earnings release
05/17MCKESSON IDEASHARE : The Independent's Power to Perform
AQ
05/14MCKESSON : U.K. Best Practices for Your Independent Pharmacy on Better Patient C..
PU
05/11MCKESSON : NLRB Regional Director Issues Decision on McKesson V. Teamsters
AQ
05/09Opioid distributors say 'pill dumping' won't happen again
AQ
05/08Opioid Shipments to Small Towns Come Under Spotlight at Hearing
DJ
05/07House Energy and Commerce Committee - Hearing
AQ
05/07MCKESSON : Why Drug Spend Analytics Should Be at the Center of Your Hospital Pha..
PU
05/07MCKESSON : Six Ideas to Help Your Independent Pharmacy Provide Better Care
PU
More news
News from SeekingAlpha
05/16Mexico Sees Slim Chances For A New NAFTA Deal; The IEA Expects The Oil Price .. 
05/16WALL STREET BREAKFAST : Clock Ticks Down For New NAFTA 
05/16More states sue over opioid epidemic 
05/15Glenview added Express Scripts, exited Apple in Q1 
05/15Tracking Seth Klarman's Baupost Group Holdings - Q1 2018 Update 
Financials ($)
Sales 2018 208 B
EBIT 2018 3 535 M
Net income 2018 1 076 M
Debt 2018 4 003 M
Yield 2018 0,83%
P/E ratio 2018 31,98
P/E ratio 2019 14,96
EV / Sales 2018 0,17x
EV / Sales 2019 0,16x
Capitalization 31 155 M
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 176 $
Spread / Average Target 18%
EPS Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
Britt Vitalone Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Marie L. Knowles Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION-3.18%31 155
CVS HEALTH CORPORATION-9.30%66 855
WALGREENS BOOTS ALLIANCE-9.13%65 440
EXPRESS SCRIPTS HOLDING CO0.00%42 887
AMERISOURCEBERGEN-7.68%19 138
CARDINAL HEALTH-12.96%17 098